Synthetic form of cancer protein created

Published: Sept. 16, 2008 at 1:27 PM

MILWAUKEE, Sept. 16 (UPI) -- U.S. medical scientists say they have created a synthetic form of a protein that is involved in certain types of cancer and immune system diseases.

Researchers at the Medical College of Wisconsin-Milwaukee said they have applied for a patent on the protein, CXCL12, which is known as a chemokine. Chemokines are proteins that regulate the movement of cells into tissues and recruit infection-fighting white blood cells to infected and injured sites, the scientists said.

The study was led by Associate Professor Brian Volkman and was based on seminal reports by Associate Professor Michael Dwinell.

"We hope that stable synthetic versions of CXCL12 will allow us to conduct proof-of-concept studies about cancer prevention," Volkman said. "It's clear that CXCL12 is an important molecule for designing new ways to treat cancer."

The research that included Christopher Veldkamp, a biochemistry graduate of the Medical College's Graduate School of Biomedical Sciences and the study's lead author, is reported in the online journal Science Signaling.

© 2008 United Press International, Inc. All Rights Reserved.
Order reprints



Additional News Stories
Bad toy choices are poorly managed risk
Scent enhances memories
Earth-like planet seen 40 light-years away
Giving the gift of higher IQ
NBA: Sacramento 112, Washington 109
You can teach an old dog new tricks
Warning: Children eat glass ornaments
fark
Catholics predictably pissed off about billboard ad that suggests the second coming might not have...
Right on schedule, it's time for the "Companies are downsizing their holiday parties" story
Do not taunt the taekwondo monkeys
Drinking beer while crossdressing is no way to go through life, son. Especially when you're just...
A teen who was flashing her breasts at passing cars was found guilty of disorderly behavior after...
Theme of Farktography Contest No. 241: "White". Details and rules in first post. LGT next week's...